(OPK) Opko Health - Ratings and Ratios

OPKO Health, Inc. is a diversified healthcare company operating in both diagnostics and pharmaceuticals, with a presence in the United States, Ireland, Spain, Chile, Israel, Mexico, and other international markets. In diagnostics, OPKO owns BioReference Laboratories, one of the largest lab testing companies in the U.S., offering a broad range of services including esoteric testing, molecular diagnostics, and womens health. Their 4Kscore® test is a notable offering for prostate cancer detection. On the pharmaceutical side, OPKO markets Rayaldee® for treating secondary hyperparathyroidism in chronic kidney disease patients and has a pipeline that includes multi-specific immune therapies, a once-weekly GLP-1 receptor agonist for diabetes and obesity, and a long-acting human growth hormone.

Financially, OPKO has a market cap of ~$1.1 billion. The company is headquartered in Miami, Florida, and was founded in 2007. Its shares trade on the NASDAQ under the ticker OPK. For more information, visit their website at https://www.opko.com.